Community Research and Development Information Service - CORDIS


Life Sciences & Biotechnology for Europe

Funded under: FP6-SUSTDEV


The European dedicated biotechnology industry directly employs 96 500 people, mostly in SMEs. Employment in industries that use biotechnology products is many times higher. The industry is highly research intensive, with 44% of its employees involved in R&D activities. In 2004, the 2163 dedicated biotechnology companies spent �7.6 billion on R&D. The EU accounted for 34.8% of biotechnology patents filed at the European Patent Office in 2002-2004, compared to 41.1% for the US.
According to a Eurobarometer survey in 2006, one in two Europeans believe that biotechnology will improve their quality of life. The survey "Europeans and Biotechnology" showed widespread support for medical and industrial applications of biotechnology, though there was a more negative position on GM foods (58% against, 42% in favour). The same survey showed that the EU is more trusted than national governments on issues of regulating biotechnology.
Taking goods and services together, the EU and the USA account for the largest bilateral trade relationship in the world. The significant amount of bilateral trade and investment illustrates a high degree of interdependence of the two economies.

Additional information

Authors: No author stated, European Commission, DG Research, Brussels (BE)
Bibliographic Reference: Luxembourg, Office for Official Publications of the European Communities, 2007. 16 pp, free of charge
Availability: Available free of charge online at:
ISBN: ISBN: 978-92-79-05000-8
Record Number: 200719187 / Last updated on: 2007-05-21
Original language: en
Available languages: en